Trial Profile

An Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Maralixibat in the Treatment of Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 08 Jul 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

29 Jun 2025 Status changed from active, no longer recruiting to completed.
28 Apr 2025 According to a Mirum Pharmaceuticals Media Release, company will present (Poster presentations) data from this trial at ESPGHAN congresses held on Friday, May 16 from 3:30-4:20pm EST.
28 Apr 2025 According to a Mirum Pharmaceuticals Media Release, company will present (Oral presentations) data from this trial at ESPGHAN congresses held on Saturday, May 17 from 1:10-2:40pm EEST and Saturday, May 17 from 9:15-11:15am EEST.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com